Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Poster Display session

318P - RA-VEIL, VEIL or O-ILND which should be used for inguinal lymphadenectomy

Date

07 Dec 2024

Session

Poster Display session

Presenters

Hongjun Yin

Citation

Annals of Oncology (2024) 35 (suppl_4): S1505-S1530. 10.1016/annonc/annonc1689

Authors

H. Yin1, W. Yang1, H. Guo2, C. Ji2

Author affiliations

  • 1 Urology Dept., Nanjing Drum Tower Hospital Clinical College of Nanjing University of Chinese Medicine, 210008 - Nanjing/CN
  • 2 Urology Dept., Nanjing Drum Tower Hospital, The Affliated Hospital of Nanjing University Medical School,, 210008 - Nanjing/CN

Resources

This content is available to ESMO members and event participants.

Abstract 318P

Background

Open IL (O-ILND) has been the gold standard for surgical treatment of the inguin, in the development of minimally invasive modifications of IL, including laparoscopic IL (VEIL) and robotic-assisted IL (RA-VEIL). They have been used to improve surgical outcomes in IL. We compared perioperative and survival outcomes among the three postoperative patients to guide the choice of minimally invasive technique for IL.

Methods

From January 2017 to June 2024, a retrospective analysis was performed on 27 admitted patients with inguinal lymph node metastases. Nine patients underwent robot-assisted videoendoscopic inguinal lymphadenectomy (RA-VEIL group n=9), 10 patients underwent laparoscopic inguinal lymphadenectomy (VEIL group n=10), and 8 patients underwent open inguinal lymphadenectomy (open group n=8).

Results

In comparing the operation time of the three groups, it can be concluded that the VEIL group (102.50±23.12) was significantly shorter than that of the O-ILND group (183.38±67.92, p<0.001). The RA-VEIL group (140.00±29.15) was significantly shorter than that in the O-ILND group (183.38±67.92, p=0.048<0.05). In comparing the intraoperative blood loss of the three groups, we found that the VEIL group (71.00±16.63) was significantly less than that in the O-ILND group (168.75±96.13, p<0.001). The RA-VEIL group (46.67±23.45) was significantly less than that in the O-ILND group (168.75±96.13, p<0.001). However, there were no significant differences in intraoperative lymph node yield, postoperative hospital stay, postoperative drainage tube removal time, and hospital cost between the RA-VEIL, VEIL, and O-ILND groups.

Conclusions

We have demonstrated that VEIL and RA-VEIL are safe and equally effective techniques, and that VEIL and RA-VEIL are comparable to and superior to O-ILND in the perioperative period compared to O-ILND in patients with inguinal lymph node metastases. VEIL and RA-VEIL should be considered as two minimally invasive options for open surgery.

Clinical trial identification

Editorial acknowledgement

Legal entity responsible for the study

The authors.

Funding

National Natural Science Foundation of China (82172777).

Disclosure

All authors have declared no conflicts of interest.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.